Clinical Trial Update: A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents [Phase 3]

View source ↗

Summary

This Phase 3 safety study compared Symbicort (budesonide/formoterol) with inhaled corticosteroid alone in asthmatic adults and adolescents, and results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Inhaled corticosteroid (inhaled corticosteroid)
• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2016-12-15